- Home
- NNBR vs NBTX Comparison
NNBR vs NBTX Comparison
Compare NNBR & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNBR
- NBTX
- Stock Information
- Founded
- NNBR 1980
- NBTX 2003
- Country
- NNBR United States
- NBTX France
- Employees
- NNBR N/A
- NBTX N/A
- Industry
- NNBR Industrial Machinery/Components
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- NNBR Industrials
- NBTX Health Care
- Exchange
- NNBR Nasdaq
- NBTX Nasdaq
- Market Cap
- NNBR 149.8M
- NBTX 178.7M
- IPO Year
- NNBR 1994
- NBTX 2020
- Fundamental
- Price
- NNBR $1.71
- NBTX $3.41
- Analyst Decision
- NNBR
- NBTX Strong Buy
- Analyst Count
- NNBR 0
- NBTX 1
- Target Price
- NNBR N/A
- NBTX $8.00
- AVG Volume (30 Days)
- NNBR 196.9K
- NBTX 7.6K
- Earning Date
- NNBR 05-07-2025
- NBTX 04-02-2025
- Dividend Yield
- NNBR N/A
- NBTX N/A
- EPS Growth
- NNBR N/A
- NBTX N/A
- EPS
- NNBR N/A
- NBTX N/A
- Revenue
- NNBR $448,780,000.00
- NBTX N/A
- Revenue This Year
- NNBR $0.82
- NBTX N/A
- Revenue Next Year
- NNBR $6.29
- NBTX $221.06
- P/E Ratio
- NNBR N/A
- NBTX N/A
- Revenue Growth
- NNBR N/A
- NBTX N/A
- 52 Week Low
- NNBR $1.58
- NBTX $2.76
- 52 Week High
- NNBR $4.67
- NBTX $7.51
- Technical
- Relative Strength Index (RSI)
- NNBR 38.01
- NBTX 52.75
- Support Level
- NNBR $1.76
- NBTX $3.26
- Resistance Level
- NNBR $1.99
- NBTX $3.65
- Average True Range (ATR)
- NNBR 0.15
- NBTX 0.19
- MACD
- NNBR 0.01
- NBTX 0.02
- Stochastic Oscillator
- NNBR 20.45
- NBTX 35.00
About NNBR NN Inc.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets. It also operates in China, Mexico, Brazil, Germany, and other countries.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.